Long‐acting beta2‐agonists versus theophylline for maintenance treatment of asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Beta2‐agonists Versus Theophylline for Maintenance Treatment of Asthma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437957/all/Implantable_loop_recorder_versus_conventional_diagnostic_workup_for_unexplained_recurrent_syncope:_Cochrane_systematic_review. Accessed 28 March 2024.
Long‐acting beta2‐agonists versus theophylline for maintenance treatment of asthma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437957/all/Implantable_loop_recorder_versus_conventional_diagnostic_workup_for_unexplained_recurrent_syncope:_Cochrane_systematic_review. Accessed March 28, 2024.
Long‐acting beta2‐agonists versus theophylline for maintenance treatment of asthma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437957/all/Implantable_loop_recorder_versus_conventional_diagnostic_workup_for_unexplained_recurrent_syncope:_Cochrane_systematic_review
Long‐acting Beta2‐agonists Versus Theophylline for Maintenance Treatment of Asthma [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437957/all/Implantable_loop_recorder_versus_conventional_diagnostic_workup_for_unexplained_recurrent_syncope:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting beta2‐agonists versus theophylline for maintenance treatment of asthma
ID - 437957
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437957/all/Implantable_loop_recorder_versus_conventional_diagnostic_workup_for_unexplained_recurrent_syncope:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -